Clinical Trial Update: Effects Of GW572016 In Combination With Docetaxel (TAXOTERE) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and preliminary activity of combining lapatinib with docetaxel (Taxotere) in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Docetaxel (Taxotere) (docetaxel)
• Lapatinib (Lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 1 | Status: COMPLETED